Company news
Mindmaze Therapeutics Holding Sa (SIX:MMTX) news
Mindmaze Therapeutics Holding Sa news releases on 6ix. Latest, Sep 17, 2026: MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based…
Press releases & updates
MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
September 17, 2026
MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences
September 1, 2026
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
August 27, 2026
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
August 12, 2026
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
August 10, 2026
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
July 9, 2026
MindMaze Therapeutics Announces Results of Annual General Meeting
June 25, 2026
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
June 3, 2026
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
June 2, 2026
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
May 26, 2026
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
May 12, 2026
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
April 30, 2026
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
April 15, 2026
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation
March 31, 2026
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
March 19, 2026
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
March 12, 2026
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
March 3, 2026
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
December 23, 2025